Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Retinoid serum plus polypodium leucotomos sunscreen for melasma in Asians
TCTR20250210003Phase 4Completed
- Sponsor
- Faculty of Medicine Siriraj Hospital, Mahidol University
- Start
- Jan 2024
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, single-arm trial of hydroxypinacolone retinoate, retinol and Polypodium leucotomos in melasma, sponsored by Faculty of Medicine Siriraj Hospital, Mahidol University. Started Jan 2024; status: completed.
02
Drugs
hydroxypinacolone retinoateretinolPolypodium leucotomos
03
Conditions
melasma
Beyond the preview
Go deeper on TCTR20250210003.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20250210003.